Depressive Disorder Clinical Trial
Official title:
Group IPT for Women Prisoners With Comorbid Substance Use and Depression
The purpose of the study is to determine whether interpersonal psychotherapy is effective for treating co-occurring depression and substance use among women prisoners.
Incarcerated women are a vulnerable and rapidly expanding population with high lifetime
rates of both substance use disorder (SUD; abuse or dependence on alcohol, illegal drugs, or
prescription drugs; 70%) and depressive disorder (DD; major depressive disorder and
dysthymic disorder; 20-27%). DDs tend to worsen the course of SUDs for incarcerated women by
increasing their risk for suicide attempts, contributing to the persistence of substance
abuse, and reducing the likelihood of a successful transition to an independent, sober life
in the community. Recent evidence indicates that DDs are common in persons with SUDs, often
do not remit with SUD treatment, and should be treated. Despite growing recognition that
co-occurring disorders, such as DDs, among substance abusing incarcerated women present an
important public health concern, integrated treatments for SUD-DD have not been
well-developed for or systematically tested in this population. Group Interpersonal
Psychotherapy (IPT-G) has been shown to be efficacious in treating DD in other populations
and may be especially pertinent to the needs of incarcerated women with SUD-DD because
interpersonal difficulties not only affect severity of depression, but are also strong
predictors of drinking to cope, SUD relapse, and prison recidivism in women.
This study tests the hypotheses that as adjuncts to prison SUD treatment, IPT-G, relative to
psychoeducation on co-occurring disorders, will produce at least moderate effect sizes for:
- Reduction in the risk and severity of substance use relapse after release from prison
- Recovery from depressive disorder and reduction in depressive symptoms
- Improvement in social support and interpersonal functioning
- Reduction in the severity of legal problems during the 3 month follow-up period
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01316926 -
Paxil CR Bioequivalence Study Brazil
|
Phase 1 | |
Recruiting |
NCT06187454 -
Transcranial Direct Current Stimulation for Depression
|
N/A | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05768126 -
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
|
Phase 4 | |
Completed |
NCT03219879 -
Telephone-administered Relapse Prevention for Depression
|
N/A | |
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT00069459 -
Seasonal Affective Depression (SAD) Study
|
Phase 1 | |
Recruiting |
NCT05503966 -
Combining Antidepressants and Attention Bias Modification in Depression
|
N/A | |
Recruiting |
NCT03001245 -
Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents
|
N/A | |
Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A | |
Completed |
NCT02542891 -
European Comparative Effectiveness Research on Internet-based Depression Treatment
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Withdrawn |
NCT02238730 -
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
Completed |
NCT01597661 -
Bupropion & Cardio Birth Defect (Slone)
|
N/A | |
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A |